Trials / Conditions / Neuroectodermal Tumor
Neuroectodermal Tumor
4 registered clinical trials studyying Neuroectodermal Tumor.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors NCT02689336 | Washington University School of Medicine | Phase 2 |
| Completed | Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor NCT01326104 | University of Florida | Phase 2 |
| Completed | Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors NCT00831844 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases NCT00513162 | M.D. Anderson Cancer Center | Phase 1 |